Alimuddin Zumla’s biography, fact, career, awards, net worth and life story

Intro Zambian physician
A.K.A. A. Zumla, A Zumla
Is Physician
Pathologist
From United Kingdom
Zambia
Type Biology
Healthcare
Gender male
Birth

15 May 1955, Chipata, Zambia

Age 65 years
Star sign Taurus
Education
University of Zambia
Awards
Donald Mackay Medal 2014
Fellow of the Royal Society of Biology  
Fellow of the African Academy of Sciences 2016
Chalmers Medal 2000
Weber-Parkes Trust Medal 2000

Sir Alimuddin Zumla, KBE, FRCP, FRCPath, FRSB (born 15 May 1955) is a British Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is internationally renowned for his extensive outputs and leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease.

Early life

Alimuddin (Ali) Zumla was born in Northern Rhodesia (now Chipata, Eastern Province, Zambia). His parents Haji Ismail and Hajiani Aman Zumla were of Gujarati Indian origin. He did his early education at the Lotus Primary School and Prince Philip Secondary School (now Kamwala Secondary School) in Lusaka, and his medical training at the University of Zambia’s School of Medicine.

In 1980, Zumla moved to London to pursue an MSc in tropical medicine at the University of London. In 1982, he contracted life-threatening tuberculous meningitis, and was told that he would never walk again, but went on to make a remarkable recovery and return to work a year and a half later to a star-studded career despite disabling and painful neurological sequelae resulting from his meningitis.

He went on to pursue doctoral studies on leprosy human monoclonal antibodies at the London School of Hygiene & Tropical Medicine, where his 1987 dissertation (advised by Keith McAdam) merited him the Alan Woodruff Medal.

Career

Following his graduation, Zumla spent a year at the London School of Hygiene and Tropical Medicine gaining the MSc degree in Clinical Tropical Diseases with a distinction and the Murgratroyd Prize. He subsequently worked at The Royal Northern and Royal Free Hospitals under the mentorship of David Geraint James obtaining his Membership of The Royal College of Physicians of London.

After doing a PhD between 1985 and 1987 he worked as infectious diseases registrar and at the Rush Green Regional Hospital for Infectious Diseases in Romford under Ming Yong and Mervyn Medlock. Whilst working at Rush Green Hospital, he identified and notified the first cases of the 1988 Legionnaires’ Diseases outbreak which he traced back to Broadcasting House, BBC, central London.

Zumla subsequently spent four years in a senior registrar/honorary lecturer position at the Hammersmith Hospital, Royal Postgraduate Medical School in London under Sir Robert Lechler, and then two years at the University of Texas Center for Infectious Diseases working with Herbert DuPont. He then returned to his native Zambia to work on AIDS-related opportunistic infections at the University Teaching Hospital in Lusaka before moving to University College London in 1994.

In 2003, there were media reports about a paper of Zumla’s in The Lancet discussing a new test developed by a team he led for monitoring CD4 immune cell counts based on dried blood samples. Such counts are used in monitoring AIDS patients taking antiretroviral drug treatments; Zumla’s subsequent work has led to development and evaluation of a range of rapid, cheap and more accessible diagnostic tests for TB and respiratory infections for use on patients in developing countries.

Zumla was the guest editor of the Lancet TB Series which addressed key issues around TB treatment and diagnosis. The launch was held at the World Health Organisation (WHO) in Geneva on 18 May 2010.
As of 2011, Zumla is the director of the Centre for Infectious Diseases and International Health at University College London Medical School, as well as a consultant in infectious diseases at University College Hospital. His current research interests include tuberculosis (particularly drug clinical trials, biomarkers, MDR-TB and TB in London), HIV/AIDS, tropical diseases, respiratory infections (and rapid diagnostics thereof), endocarditis, biomarkers, and transrenal DNA.

Zumla’s work focuses on improving global health, especially for disadvantaged populations, with an emphasis on assisting poorer and disadvantaged peoples of the world. He established and directs a multi-country collaboration with several African, Middle Eastern, European and United States institutions on collaborative research and training program on TB and HIV/AIDS. During the past two decades Zumla and his collaborators have set up research and training programs in Africa, focusing attention on development of local infrastructure and capacity development. Several of his doctoral students now occupy academic positions in institutions in Africa.

Zumla has established north–south partnerships for TB research. His collaborations now span five countries in Europe and 10 in sub-Saharan Africa, where he leads several multi-country research projects. His team’s research findings have contributed to the development of WHO’s management guidelines on treatment and prevention of TB and TB/HIV, and to improvements in the care of patients worldwide.

In 2014, together with colleagues from Public Health England, World Health Organization, London School of Hygiene and Tropical Medicine, and the Middle East, Zumla co-led The Lancet series on Mass Gatherings Medicine which was launched at the World Health Assembly of Ministers of Health in Geneva. This was a Series of reports about different mass gatherings: the London 2012 Olympic and Paralympic Games; the 2012 European Football Championship finals, hosted jointly by Poland and Ukraine; and Hajj 2012 and Hajj 2013. These reports set out the planning and surveillance systems used to monitor public health risks, and describe the public health experiences and lessons learnt for the planning of future events.

Zumla played a lead role in defining the etiology, epidemiology, mode of transmission of the new lethal virus, the Middle East respiratory syndrome coronavirus.

Zumla is a member of the Court of Governors of the London School of Hygiene and Tropical Medicine and is Vice Chair of the Strategic Advisory Group to the European and Developing Countries Clinical Trials Partnership

On 7 April 2015 at an inaugural meeting in Cape Town, South Africa, Zumla and Markus Maeurer from Karolinska Institutet Sweden led and established a new initiative, the Host-Directed Therapies Network (HDT-NET) consortium of 64 global partners to tackle global infectious diseases threats of multi-drug resistant TB and antimicrobial resistance.

Awards

Zumla has received the Weber Parkes Trust Medal and Prize from the Royal College of Physicians of London in 1999; the Albert Chalmers Medal from the Royal Society of Tropical Medicine and Hygiene in 2002; the Windrush Award for Academic Achievement in 2003; and the 2005 Professional of the year by the “Muslim News” The Muslim News2005 Awards for Excellence. In 2011 and 2012, Zumla received the UK India International Foundation Science Award (2011); the University of Amsterdam Spinoza Leerstoel award (2011); and the World Health Organisation (WHO) STOP TB Partnership Kochon Prize and Medal (2011) and the Karolinska Institutet, Sweden 2012 Annual Science Prize (2012) and honorary doctorate (2016).

In October 2012, Zumla was awarded the highest Zambian civilian award by then Zambian president Michael Sata for his outstanding contributions to infectious diseases research in sub-Saharan Africa, development of Zambia’s health sector, and training of numerous health personnel. The award, The Grand Commander of the Order of Distinguished Services First Division, was bestowed on Zumla on the 48th anniversary of Zambia’s Independence. In 2016 a research consortium led by Zumla won the European and Developing Countries Clinical Trials Partnership prize presented by Zambian President Edgar Lungu. In 2017 Zumla was appointed as National Institute for Health Research a senior investigator.

Quotes

“Everyone should hold hands together and move forward in the fight against killer infectious diseases”

Selected works

Zumla has authored more than 500 publications and edited/published 19 medical textbooks, three of which are globally acknowledged classics: Manson’s Tropical Diseases 21st and 22nd editions, Tuberculosis: A Comprehensive Clinical Reference which involves 156 global TB experts writing 104 chapters on all aspects of paediatric and adult TB, and Granulomatous Disorders co-edited with D. G. James.

Books

  • Zumla, Alimuddin; Johnson, Margaret A.; Miller, Robert (1997), AIDS and respiratory medicine, Chapman & Hall Medical, ISBN 978-0-412-60140-8
  • Zumla, Alimuddin; Schaaf, H. Simon (2009), Tuberculosis: An Issue of Clinics in Chest Medicine, Elsevier – Health Sciences Division, ISBN 978-1-4377-1804-1
  • Zumla, Alimuddin, Behrens, Ronald H., Memish, Ziad A., Travel Medicine, An Issue of Infectious Disease Clinics (1st ed.), Philadelphia, PA, ISBN 9781455748983, OCLC 815361562CS1 maint: uses authors parameter (link)
  • H. Simon Schaaf and Alimuddin Zumla, Tuberculosis: A Comprehensive Clinical Reference

Edited works

  • Cook, Gordon C; Zumla, Alimuddin, eds. (2008), Manson’s Tropical Diseases (22nd ed.), London: Elsevier Harcourt Brace Publishing Group, ISBN 978-1-4160-4470-3
  • Schaaf, H. Simon; Zumla, Alimuddin, eds. (2009), Tuberculosis: a comprehensive clinical reference, Saunders/Elsevier, ISBN 978-1-4160-3988-4

Journal papers

  • McCloskey, B.; Endericks, T.; Catchpole, M.; Zambon, M.; McLauchlin, J.; Shetty, N.; Manuel, R.; Turbitt, D.; Smith, G.; Crook, P.; Severi, E.; Jones, J.; Ibbotson, S.; Marshall, R.; Smallwood, C. A. H.; Isla, N.; Memish, Z. A.; Al-Rabeeah, A. A.; Barbeschi, M.; Heymann, D. L.; Zumla, A. (2014). “London 2012 Olympic and Paralympic Games: Public health surveillance and epidemiology”. The Lancet. 383 (9934): 2083–2089. doi:10.1016/S0140-6736(13)62342-9. PMID 24857700.
  • Zumla A., Raviglione M., Hafner R., Fordham, von Reyn C. (2013). “Tuberculosis”. New England Journal of Medicine. 368 (8): 745–755. doi:10.1056/NEJMra1200894. PMID 23425167.CS1 maint: multiple names: authors list (link)
  • Nunn, Andrew J.; Mwaba, Peter B.; Chintu, Chifumbe; Crook, Angela M.; Darbyshire, Janet H.; Ahmed, Yusuf; Zumla, Alimuddin I. (April 2011), “Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ)”, Tropical Medicine & International Health, 16 (4): 518–526, doi:10.1111/j.1365-3156.2011.02731.x, PMID 21281407
  • Griffiths, C.; Sturdy, P.; Brewin, P.; Bothamley, G.; Eldridge, S.; Martineau, A.; MacDonald, M.; Ramsay, J.; Tibrewal, S.; Levi, S.; Zumla, A.; Feder, G. (2007). “Educational outreach to promote screening for tuberculosis in primary care: A cluster randomised controlled trial”. The Lancet. 369 (9572): 1528–34. doi:10.1016/S0140-6736(07)60707-7. PMID 17482983.
  • Perkins, M. D.; Roscigno, G.; Zumla, A. (2006), “Progress towards improved tuberculosis diagnostics for developing countries”, The Lancet, 367 (9514): 942–3, doi:10.1016/S0140-6736(06)68386-4, PMID 16546544
  • Zumla, A; Mullan, Z (2006), “Turning the tide against tuberculosis”, The Lancet, 367 (9514): 877–8, doi:10.1016/S0140-6736(06)68355-4, PMID 16546520
  • Chintu, C.; Bhat, G. J.; Walker, A. S.; Mulenga, V.; Sinyinza, F.; Lishimpi, K.; Farrelly, L.; Kaganson, N.; Zumla, A.; Gillespie, S. H.; Nunn, A. J.; Gibb, D. M. (2004). “Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): A double-blind randomised placebo-controlled trial”. The Lancet. 364 (9448): 1865–71. doi:10.1016/S0140-6736(04)17442-4. PMID 15555666.
  • Mwaba, P.; Cassol, S.; Pilon, R.; Chintu, C.; Janes, M.; Nunn, A.; Zumla, A. (2003), “Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients”, The Lancet, 362 (9394): 1459–60, doi:10.1016/S0140-6736(03)14693-4, PMID 14602443
  • Mwaba, P.; Cassol, S.; Nunn, A.; Pilon, R.; Chintu, C.; Janes, M.; Zumla, A. (2003), “Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients”, The Lancet, 362 (9401): 2067–8, doi:10.1016/S0140-6736(03)15103-3, PMID 14697808
  • Chintu, C.; Mudenda, V.; Lucas, S.; Nunn, A.; Lishimpi, K.; Maswahu, D.; Kasolo, F.; Mwaba, P.; Bhat, G.; Terunuma, H.; Zumla, A. (2002), “Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study”, The Lancet, 360 (9338): 985–90, doi:10.1016/S0140-6736(02)11082-8, PMID 12383668
  • Mwinga, A.; Nunn, A.; Ngwira, B.; Chintu, C.; Warndorff, D.; Fine, P.; Darbyshire, J.; Zumla, A. (2002), “Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial”, The Lancet, 360 (9339): 1050–5, doi:10.1016/S0140-6736(02)11141-X, PMID 12383985
You May Also Like

Will Smith’s net worth, biography, fact, career, awards and life story

Will Smith Net Worth and Salary: Will Smith is an actor, film producer and rapper who has a net worth of $350 million. Every year, Will Smith earns at least $40 million from his various endeavors and has earned as much as $80 million in some years. For example, between June 2019 and June 2020, Will earned $45 million from his various endeavors, primarily film salaries. At the peak of his career in the 2000s, Will earned $20 – $30 million per movie. In recent years he has earned massive single-film salaries from Netflix. He reportedly earned $20 million for the 2017 Netflix movie “Bright” and $35 million for its sequel. He is also somewhat of a social media superstar. As of this writing Will has more than 45 million followers on Instagram, 8 million subscribers on YouTube and 30 million followers on Tik Tok. Early Life: Will Smith was born and raised in West Philadelphia of modest beginnings as the son of a school administrator and refrigerator engineer. One of his childhood friends was Jeffrey Allen Townes, who was a popular local DJ and was eventually known as DJ Jazzy Jeff. They met by chance when Jeff was performing down the street and needed a hype man. Smith jumped at the chance and the two had instant chemistry. They would eventually form a group called DJ Jazzy Jeff & The Fresh Prince. In 1986 they caught the year of Russell Simmons at Def Jam Records who signed them to a deal. Their debut album “Rock the House” was released in 1987. The album went gold. Their second album “He’s the DJ, I’m the Rapper” was released in 1988. It was a smash hit, selling more than three million copies. In total, the duo would release five albums together. In 1988, Will earned the first Grammy ever for the newly formed Rap category. IRS Problems: Between 1988 and 1990, Will Smith earned approximately $10 million from his musical career.  Assuming the good times would last forever, Will proceeded to spend his money like it was going out of style. He purchased houses, cars, clothes, jewelry and much more. He didn’t just spoil himself, he also spoiled his friends and family. Unfortunately, right around the time he won the Grammy, radio audiences were beginning to grow tired of Will and Jazzy Jeff. Their “radio-friendly” songs were suddenly being sneered at as “rap sell-outs”. Also, unfortunately, during the high times, Will was not paying his taxes. At 21 years old, Will was informed that he neglected to pay $2.8 million worth of taxes during his fat years. That’s the same as around $6 million worth of debt after adjusting for inflation. Around this time, Will was approached by super-producer Quincy Jones about starring in a television show. Initially, Will vehemently rejected the idea of starring in a TV sitcom. He was terrified that this would make him look like even more of a sellout. But on the plus side, the gig came with a large paycheck. If the show was renewed for more seasons, the salary would go up. With the not-so-subtle encouragement from the IRS, Will signed on to star in the newly titled sitcom “The Fresh Prince of Bel Air”. The IRS also arranged to have 70% of Will’s salary garnished until his debt was completely paid off. During an interview with 60 Minutes years later, Will said the following about his early TV days: “For the first three years of The Fresh Prince of Bel-Air, the IRS was taking 70 percent of every check and after the third year I got back to zero. It’s terrible to have that kind of success and have to quietly be broke.” Film Star: Riding high from his hit sitcom, in 1993 Will was paid $500,000 to star in “Six Degrees of Separation”, for which he received critical acclaim. His movie career took off in a big way in 1995, when he co-starred in the hit action-comedy, “Bad Boys”, for which he earned $2 million. Years later he would earn $20 million to appear in the sequel. Will Smith Biggest Paychecks: In the 20 years between 1993 and 2013, Will earned $200 million in movie salaries and bonuses. As of this writing, his movie earnings easily top $300 million, perhaps much more if some of his reported backend deals are accurate. Will’s biggest confirmed payday came in 2013 when he earned $20 million in upfront salary and $80 million in backend points from Men In Black 3 thanks to his 10% cut of the gross. He reportedly also had 20% of the gross of Bad Boys 2, Hancock, and Pursuit of Happyness. Though it could be possible that he actually had 20% of net profits, as opposed to gross which would be significantly different numbers. If he indeed has gross points he would have earned $355 million from those four movies alone. His largest upfront payday was the $28 million he earned for I, Robot. In 2018 he earned $20 million to star in Netflix’s Bright. Netflix is reportedly paying Will $35 million to reprise his role in Bright 2. Music Career: Smith never left music, and while working simultaneously on his films he released four solo albums, two which have gone platinum. Smith had numerous hit singles, among them “Men in Black,” and “Gettin’ Jiggy Wit It,” earning Smith two consecutive Grammy Awards for Best Rap Solo Performance. Awards: Smith was twice nominated for an Academy Award, both for portraying real people, Muhammad Ali in “Ali” and Chris Gardner in “The Pursuit of Happyness”. Among his awards, Smith has two BET Awards, one Image Award, four MTV Movie Awards, and two People’s Choice Awards. Personal Life: Will has two children with his wife, Jada Pinkett, his wife since 1997. Their children, Jaden Smith and Willow Smith, are both in the entertainment industry. He also has a son named Trey with his first wife, Sheree Ampino. Will Smith Net Worth from Real Estate: In 1999 Will and Jada spent $7.5 million to acquire a stunning 100-acre property in the hills between Malibu and Calabasas, California. Over the next year they bought several nearby parcels to string together 150-acres of contiguous land. The property features a 20,000 square-foot main house, several guest houses, a private lake, a horse riding ring, equestrian trails, stables, tennis courts and much more. They designed the property in a Santa Fe style after falling in love with actor Gene Hackman’s Santa Fe home. They actually hired Hackman’s Santa Fe architect for the project which took years to kick-off due to environmental concerns and permit restrictions. In 2013 they quietly listed the property for $42 million but did not find a buyer. Today this property alone is likely worth $50 – $70 million. In 2017 Will and Jada sold their 7-acre oceanfront compound in Kauai for $12 million. They bought the multi-home property in 2015 for $10 million. In 2011 they sold a different oceanfront Hawaiian property on 7-acres for $20 million to Ekaterina Rybolovlev, the daughter of billionaire Russian oligarch Dmitry Rybolovlev. They also own a 9,000 square foot home located in a gated community Hidden Hills, California and a 9,200 square-foot ski chalet in Park City, Utah. In total, the Smiths own at least $100 million worth of real estate around the world that we know about. Summary: Will Smith has a net worth of $350 million. He is one of the highest-paid actors of the last twenty years, having earned hundreds of millions of dollars in move salaries alone. Will and his wife Jada own an impressive real estate portfolio that includes properties around the country.
Read More